Wearable heart watch put to the test against hospital ECG
NCT ID NCT07624435
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a wearable HeartWatch device to a standard 12-lead ECG in 40 adults. Researchers check if the watch accurately measures heart intervals like QRS and P wave durations in different positions. The goal is to see if the wearable can reliably monitor heart health outside a clinic.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HeartWatch wearable ECG device
- What this could lead to
- If successful, this could validate a wearable device for accurate heart monitoring outside clinics.
- What could go wrong
- This is a small, early-stage study with only 40 participants. It tests accuracy in controlled positions, not real-world use, and may not detect all heart issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECG MONITORING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
-
University of Calgary
Calgary, Alberta, T2N 4N1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.